In addition, it was found that serum FGF23 was significantly associated with LVEF among patients with CKD stages G1/G2 and G3a (Table 3); unexpectedly, however, the relationship was insignificant among patients with more severe renal dysfunction (CKD G3-G5). This evidence concerns the gene FGF23 and chronic kidney disease.